Long-term Outcomes of Laparoscopic Sacrohysteropexy with SERATEX^® SlimSling^® Mesh: A Retrospective Case Series

Pelvic organ prolapse (POP) surgery has evolved toward minimally invasive techniques. Laparoscopic sacrohysteropexy (LSHP) is associated with reduced morbidity and lower mesh exposure risks. This study evaluates the long-term outcomes of LSHP using the SERATEX^® SlimSling^® mesh for isolated uterine prolapse.

A retrospective case series was conducted on patients who underwent LSHP with SERATEX^® SlimSling^® mesh for apical prolapse with uterine preservation between 2014 and 2020. Data were extracted from medical records, including demographics, intraoperative details, and postoperative outcomes. Modified POP-Q measurements (Ba, Bp, C, D) were recorded. Patients were assessed perioperatively and at multiple postoperative intervals, with follow-up via telephone interviews by a urogynecologist. Statistical analysis included descriptive statistics and univariate analysis, with a p value of less than 0.05 considered significant.

Twenty-five women underwent LSHP with a mean age of 46 years. Most patients had isolated apical prolapse without other symptoms. Intraoperatively, 75% had concomitant cervical shortening, 10% had anterior colporrhaphy, and 30% had mid urethral sling, with a mean surgery duration of 112 min and no postoperative complications. Median follow-up was 66 months. Three patients (12%) experienced prolapse recurrence, mainly cystocele with two requiring reoperations. Four patients conceived and delivered post-procedure, all via cesarean section. At the long-term telephone interview, 76.2% were very happy with the surgery, 14.3% happy, and 9.5% unhappy.

LSHP with the SERATEX^® SlimSling^® mesh for isolated uterine prolapse demonstrates a fair safety profile, durable outcomes, high patient satisfaction, and favorable pregnancy outcomes. This procedure offers a viable, minimally invasive option for uterine preservation.